Cancer Institute A national cancer institute
designated cancer center

Samuel So

Publication Details

  • Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo.

    Yan X, Chua MS, He J, So SK. Mol Cancer. 2008: 7 19

    Using gene expression profiling, we previously identified CDC25B to be significantly highly expressed in hepatocellular carcinoma (HCC) compared to non-tumor liver. CDC25B is a cell cycle-activating phosphatase that positively regulates the activity of cyclin-dependent kinases, and is over-expressed in a variety of human malignancies. In this study, we validated the over-expression of CDC25B in HCC, and further investigated its potential as a therapeutic target for the management of HCC.

    PubMedID: 18269767

Stanford Medicine Resources:

Footer Links: